The Institute of Metabolic Disease (IMD), part of Baylor Scott & White Research Institute, develops analytical tests for clinical diagnosis, performs clinical testing and research testing and explores therapeutic approaches that encompass the complementary fields of metabolomics and metabolic disease.

Metabolomics is the quantitative measurement of small-molecule metabolites (metabolic Intermediates, hormones and other signaling molecules, and secondary metabolites) found in a biological sample. Metabolomes are considered to be down stream of both gene and protein expression and reflect both transcriptional and translational processes. Metabolic profiling provides insight into intra- and extra-cellular regulatory processes involved in metabolic adaption for each individual phenotype.